195 related articles for article (PubMed ID: 11079738)
1. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease.
Flyvbjerg A
Diabetologia; 2000 Oct; 43(10):1205-23. PubMed ID: 11079738
[TBL] [Abstract][Full Text] [Related]
2. Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complications of diabetes.
Flyvbjerg A
Kidney Int Suppl; 1997 Sep; 60():S12-9. PubMed ID: 9285896
[TBL] [Abstract][Full Text] [Related]
3. Diabetic microvascular complications and growth factors.
Pfeiffer A; Schatz H
Exp Clin Endocrinol Diabetes; 1995; 103(1):7-14. PubMed ID: 7621107
[TBL] [Abstract][Full Text] [Related]
4. Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy.
Ichinose K; Kawasaki E; Eguchi K
Am J Nephrol; 2007; 27(6):554-64. PubMed ID: 17823503
[TBL] [Abstract][Full Text] [Related]
5. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195.
Tsuchida K; Makita Z; Yamagishi S; Atsumi T; Miyoshi H; Obara S; Ishida M; Ishikawa S; Yasumura K; Koike T
Diabetologia; 1999 May; 42(5):579-88. PubMed ID: 10333051
[TBL] [Abstract][Full Text] [Related]
6. Vascular growth factors and the development of macrovascular disease in diabetes mellitus.
Koschinsky T; Bünting CE; Rütter R; Gries FA
Diabete Metab; 1987 Jul; 13(3 Pt 2):318-25. PubMed ID: 3308559
[TBL] [Abstract][Full Text] [Related]
7. Growth factors and diabetic retinopathy.
Paques M; Massin P; Gaudric A
Diabetes Metab; 1997 Apr; 23(2):125-30. PubMed ID: 9137900
[TBL] [Abstract][Full Text] [Related]
8. Inhibition and reversibility of renal changes: lessons from diabetic kidney disease.
Flyvbjerg A
Acta Paediatr Suppl; 2006 Apr; 95(451):83-92. PubMed ID: 16720472
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A
Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
[TBL] [Abstract][Full Text] [Related]
10. Growth factors and cytokines in acute renal failure.
Harris RC
Adv Ren Replace Ther; 1997 Apr; 4(2 Suppl 1):43-53. PubMed ID: 9113240
[TBL] [Abstract][Full Text] [Related]
11. New concepts in pathogenesis and treatment of diabetic retinopathy.
Spranger J; Pfeiffer AF
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S438-50. PubMed ID: 11460590
[TBL] [Abstract][Full Text] [Related]
12. The role of human and viral cytokines in the pathogenesis of multiple myeloma.
Berenson JR; Sjak-Shie NN; Vescio RA
Semin Cancer Biol; 2000 Oct; 10(5):383-91. PubMed ID: 11100886
[TBL] [Abstract][Full Text] [Related]
13. Central role of TGF-beta in the pathogenesis of diabetic nephropathy and macrovascular complications: a hypothesis.
Yokoyama H; Deckert T
Diabet Med; 1996 Apr; 13(4):313-20. PubMed ID: 9162605
[TBL] [Abstract][Full Text] [Related]
14. Role of cytokines in pathogenesis of endometriosis.
Barcz E; Kamiński P; Marianowski L
Med Sci Monit; 2000; 6(5):1042-6. PubMed ID: 11208452
[TBL] [Abstract][Full Text] [Related]
15. Role of growth factors in diabetic kidney disease.
Chiarelli F; Gaspari S; Marcovecchio ML
Horm Metab Res; 2009 Aug; 41(8):585-93. PubMed ID: 19452424
[TBL] [Abstract][Full Text] [Related]
16. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
Nosadini R; Brocco E
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
[TBL] [Abstract][Full Text] [Related]
17. Compensatory glomerular growth after unilateral nephrectomy is VEGF dependent.
Flyvbjerg A; Schrijvers BF; De Vriese AS; Tilton RG; Rasch R
Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E362-6. PubMed ID: 12110543
[TBL] [Abstract][Full Text] [Related]
18. Diabetic kidney disease: impact of puberty.
Lane PH
Am J Physiol Renal Physiol; 2002 Oct; 283(4):F589-600. PubMed ID: 12217849
[TBL] [Abstract][Full Text] [Related]
19. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.
Daniel C; Schaub K; Amann K; Lawler J; Hugo C
Diabetes; 2007 Dec; 56(12):2982-9. PubMed ID: 17878288
[TBL] [Abstract][Full Text] [Related]
20. Growth factors, cytokines, and renal fibrosis during the course of diabetic nephropathy.
Rossert J; Terraz-Durasnel C; Brideau G
Diabetes Metab; 2000 Jul; 26 Suppl 4():16-24. PubMed ID: 10922969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
